Digestive Disease Interventions 2018; 02(04): 375-382
DOI: 10.1055/s-0038-1675593
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Endoscopic Bariatric/Metabolic Surgery

Daanish Kazi
1   University Hospitals, Cleveland Medical Center, Cleveland, Ohio
,
Leena Khaitan
1   University Hospitals, Cleveland Medical Center, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

26 September 2018

04 October 2018

Publication Date:
10 December 2018 (online)

Abstract

Endoscopic approaches to the bariatric patient have increased significantly in the last two decades. Obese patients present a challenge to surgeons as they are at higher risk of having perioperative complications. Patients also are seeking less and less invasive ways to have procedures performed. The combination of these two demands has led to the development of new technologies in the bariatric arena. Now there are several new endoscopic approaches for primary weight loss. Endoscopic metabolic procedures are developing for the management of diabetes. This article reviews the latest in these technologies.

 
  • References

  • 1 Štimac D, Klobučar Majanović S, Ličina M. Recent trends in endoscopic management of obesity. Surg Innov 2016; 23 (05) 525-537
  • 2 Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017; 152 (07) 1791-1801
  • 3 Gaur S, Levy S, Mathus-Vliegen L, Chuttani R. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc 2015; 81 (06) 1330-1336
  • 4 Genco A, Bruni T, Doldi SB. , et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg 2005; 15 (08) 1161-1164
  • 5 Lopez-Nava G, Rubio MA, Prados S. , et al. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011; 21 (01) 5-9
  • 6 Zerrweck C, Maunoury V, Caiazzo R. , et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg 2012; 22 (05) 777-782
  • 7 Dastis NS, François E, Deviere J. , et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009; 41 (07) 575-580
  • 8 Neto MG, Silva LB, Grecco E. , et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis 2018; 14 (02) 151-159
  • 9 Ponce J, Woodman G, Swain J. , et al; REDUCE Pivotal Trial Investigators The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015; 11 (04) 874-881
  • 10 Carvalho GL, Barros CB, Moraes CE. , et al. The use of an improved intragastric balloon technique to reduce weight in pre-obese patients--preliminary results. Obes Surg 2011; 21 (07) 924-927
  • 11 Mion F, Ibrahim M, Marjoux S. , et al. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg 2013; 23 (05) 730-733
  • 12 Trande P, Mussetto A, Mirante VG. , et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg 2010; 20 (09) 1227-1230
  • 13 Genco A, Ernesti I, Ienca R. , et al. Safety and efficacy of a new swallowable intragastric balloon not needing endoscopy: early Italian experience. Obes Surg 2018; 28 (02) 405-409
  • 14 https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm609757.htm
  • 15 Tate CM, Geliebter A. Intragastric balloon treatment for obesity: FDA safety updates. Adv Ther 2018; 35 (01) 1-4
  • 16 Ali MR, Moustarah F, Kim JJ. ; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Obes Relat Dis 2016; 12 (03) 462-467
  • 17 Huang CS, Farraye FA. Complications following bariatric surgery. Tech Gastrointest Endosc ••• 8. 54-56
  • 18 Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther 2017; 34 (08) 1859-1875
  • 19 Bazerbachi F, Haffar S, Sawas T. , et al. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes Surg 2018; 28 (09) 2617-2625
  • 20 Gagner M. Comment on Brazilian Intragastric Balloon Consensus Statement (BIBC): practical recommendations based on experience of over 40,000 cases. Surg Obes Relat Dis 2018; 14 (02) 159-161
  • 21 Lopasso FP, Sakai P, Gazi BM. , et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol 2008; 42 (01) 48-53
  • 22 Sauer N, Rösch T, Pezold J. , et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg 2013; 23 (11) 1727-1733
  • 23 Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008; 68 (01) 51-58
  • 24 Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis 2010; 6 (06) 689-694
  • 25 Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G. , et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc 2018; 32 (04) 2159-2164
  • 26 Sartoretto A, Sui Z, Hill C. , et al. Endoscopic Sleeve Gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg 2018; 28 (07) 1812-1821
  • 27 Fayad L, Adam A, Dunlap M. , et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc 2018 Doi: 10.1016/j.gie.2018.08.030
  • 28 Familiari P, Costamagna G, Bléro D. , et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 2011; 74 (06) 1248-1258
  • 29 Moreno C, Closset J, Dugardeyn S. , et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40 (05) 406-413
  • 30 Vilarrasa N, de Gordejuela AG, Casajoana A. , et al. Endobarrier® in grade I obese patients with long-standing type 2 diabetes: role of gastrointestinal hormones in glucose metabolism. Obes Surg 2017; 27 (03) 569-577
  • 31 Ellsmere JC, Thompson CC, Brugge WR. , et al. Endoscopic interventions for weight loss surgery. Obesity (Silver Spring) 2009; 17 (05) 929-933
  • 32 Tarnoff M, Rodriguez L, Escalona A. , et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009; 23 (03) 650-656
  • 33 Schouten R, Rijs CS, Bouvy ND. , et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010; 251 (02) 236-243
  • 34 Sandler BJ, Rumbaut R, Swain CP. , et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 2015; 29 (11) 3298-3303
  • 35 Rajagopalan H, Cherrington AD, Thompson CC. , et al. Galvao Neto M. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6 months interim analysis from the first-in-human proof-of-concept study. Diabetes Care 2016; 39 (12) 2254-2261
  • 36 Thompson CC, Abu Dayyeh BK, Kushner R. , et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 2017; 112 (03) 447-457
  • 37 Nyström M, Machytka E, Norén E. , et al. Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-patient multi-center post-market European Registry Study. Obes Surg 2018; 28 (07) 1860-1868
  • 38 Machytka E, Buzga M, Ryou M, Lautz DB, Thompson CC. 1139 Endoscopic dual-path enteral anastomosis using self assembling magnets: fist-in-human clinical feasibility. Gastroenterology 2016; 150: s232
  • 39 Kurian M, Kroh M, Chand B, Mikami D, Reavis K, Khaitan L. SAGES review of endoscopic and minimally invasive bariatric interventions: a review of endoscopic and non-surgical bariatric interventions. Surg Endosc 2018; 32 (10) 4063-4067